EVOKE PHARMA, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value

EVOKE PHARMA, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value

EVOKE PHARMA, INC. had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $56.00 thousand as of 2012-12-31, per its 10-K filed 2014-03-25.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2014-03-25

• 2012-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $56.00K.
• 2011-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $39.00K.